Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endothelium

Proc Natl Acad Sci U S A. 1990 Jul;87(13):5183-7. doi: 10.1073/pnas.87.13.5183.

Abstract

Tumor necrosis factor and immune interferon synergistically increase cell-surface expression of class I major histocompatibility complex molecules in cultured human endothelial cells. We report that tumor necrosis factor and interferon gamma each independently increase mRNA levels and together cause a greater-than-additive (i.e., synergistic) increase in steady-state mRNA levels and transcriptional rates of the class I heavy- and light-chain genes. HLA heavy-chain mRNA is equally stable in cytokine-treated and -untreated endothelial cells. Interferon gamma does not increase tumor necrosis factor receptor number or affinity on human endothelial cells. We conclude that the synergistic increase in class I major histocompatibility complex cell-surface expression results principally from the synergistic increase in transcriptional rates. We propose that this increase is caused by the cooperative binding of independently activated transcription factors to the promoter/enhancer sequences of class I genes.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Base Sequence
  • Cell Nucleus / metabolism
  • Cells, Cultured
  • Drug Synergism
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / immunology*
  • Flow Cytometry
  • Genes, MHC Class I / drug effects*
  • Histocompatibility Antigens Class I / genetics
  • Humans
  • Interferon Type I / pharmacology*
  • Interferon-gamma / pharmacology*
  • Macromolecular Substances
  • Molecular Sequence Data
  • RNA, Messenger / analysis
  • RNA, Messenger / genetics
  • Receptors, Cell Surface / metabolism
  • Receptors, Tumor Necrosis Factor
  • Recombinant Proteins / pharmacology*
  • Sequence Homology, Nucleic Acid
  • Transcription, Genetic / drug effects*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Histocompatibility Antigens Class I
  • Interferon Type I
  • Macromolecular Substances
  • RNA, Messenger
  • Receptors, Cell Surface
  • Receptors, Tumor Necrosis Factor
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma